Following the acquisition, Aegera’s 20 plus employees will be joining Pharmascience’s team.
The acquisition will allow Pharmascience to enhance its research and development activities through the continuance of Aegera’s programs.
Pharmascience president and COO Mario Deschamps said they are pleased to welcome Aegera’s employees to their team, which will broaden and strengthen the development of their organization.